Security Most Important Factor In DRC Ebola Outbreak, Health Minister Says, Calls For Regulatory Approval Of Merck Vaccine; WHO Appoints Emergency Ebola Response Coordinator

Al Jazeera: Fears of Ebola pandemic if violent attacks continue in DR Congo
“Health officials have warned that the second-deadliest outbreak of Ebola may spiral out of control unless attacks by armed groups on medical facilities and workers in the Democratic Republic of the Congo (DRC) stop…” (Bibbo, 5/22).

Reuters: U.N. creates new Ebola chief role to tackle security, political issues in Congo
“The United Nations named an Emergency Ebola Response Coordinator on Thursday, creating a new position to boost efforts to contain a 10-month epidemic in the Democratic Republic of Congo that has killed more than 1,200 people. … David Gressly, currently deputy chief of the U.N.’s MONUSCO peacekeeping mission in Congo, has been appointed to the new post, the statement said…” (Nebehay, 5/23).

Reuters: Congo wants more use of Merck vaccine rather than J&J newcomer: minister
“Democratic Republic of Congo called on Wednesday for Merck’s experimental Ebola vaccine to be fully licensed to facilitate its use in the Ebola-hit country, while saying Johnson & Johnson’s rival [experimental vaccine] would complicate matters. … ‘It would perturb the population to be faced with several different types of vaccines and that would muddle the message, and, as you know in a complex outbreak response, the message needs to be simple and clear,’ [Congolese Health Minister Oly Ilunga Kalenga] said…” (Miles, 5/22).

Additional coverage of the DRC Ebola outbreak and response is available from CBS News and CIDRAP News.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.